Mounzer Maaz, Samar Maaz, Islam Maaz, Randa Dardari, Helene Dardari, Dured Dardari
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050
10.1016/s2213-8587(25)00299-2 · 2026
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
10.1007/s00125-022-05787-2 · 2022
Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people
10.2337/dc13-0331 · 2013
Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes
10.1056/nejmoa1907863 · 2019
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study
10.1016/s2213-8587(22)00212-1 · 2022
Trial of hybrid closed-loop control in young children with type 1 diabetes
10.1056/nejmoa2210834 · 2023
American Diabetes Association Professional Practice Committee for Diabetes. 7. Diabetes technology: Standards of Care in Diabetes—2026. Diabetes Care
2026
Global epidemiology and burden of type 2 diabetes in adults aged 55 and older: insights from 1990 to 2021
10.1177/20420188251362011 · 2025
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
europepmc
Confidence 96%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
High prevalence of comorbidities in older adult patients with type 2 diabetes: a cross-sectional survey
10.1186/s12877-024-05483-3 · 2024
Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices
10.1038/s41746-018-0040-6 · 2018
A deep learning system for predicting time to progression of diabetic retinopathy
10.1038/s41591-023-02702-z · 2024
A randomized trial of automated insulin delivery in type 2 diabetes
10.1056/nejmoa2415948 · 2025
Real-time AI-assisted insulin titration system for glucose control in patients with type 2 diabetes: a randomized clinical trial
10.1001/jamanetworkopen.2025.8910 · 2025
Artificial intelligence for diabetes care: current and future prospects
10.1016/s2213-8587(24)00154-2 · 2024
10.1109/cogsima61085.2024.10553768
10.1109/cogsima61085.2024.10553768
Artificial intelligence for diabetes care: current and future prospects
10.1016/s2213-8587(24)00154-2 · doi-reference
Real-time AI-assisted insulin titration system for glucose control in patients with type 2 diabetes: a randomized clinical trial
10.1001/jamanetworkopen.2025.8910 · doi-reference
A randomized trial of automated insulin delivery in type 2 diabetes
10.1056/nejmoa2415948 · doi-reference
A deep learning system for predicting time to progression of diabetic retinopathy
10.1038/s41591-023-02702-z · doi-reference
Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices
10.1038/s41746-018-0040-6 · doi-reference
High prevalence of comorbidities in older adult patients with type 2 diabetes: a cross-sectional survey
10.1186/s12877-024-05483-3 · doi-reference
Global epidemiology and burden of type 2 diabetes in adults aged 55 and older: insights from 1990 to 2021
10.1177/20420188251362011 · doi-reference
Trial of hybrid closed-loop control in young children with type 1 diabetes
10.1056/nejmoa2210834 · doi-reference
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study
10.1016/s2213-8587(22)00212-1 · doi-reference
Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes
10.1056/nejmoa1907863 · doi-reference
Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people
10.2337/dc13-0331 · doi-reference
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
10.1007/s00125-022-05787-2 · doi-reference
11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050
10.1016/s2213-8587(25)00299-2 · doi-reference
10.1109/cogsima61085.2024.10553768
10.1109/cogsima61085.2024.10553768 · doi-reference
